MarketBeat Instant News Alerts 2 hours agoCerus (NASDAQ:CERS) Earns "Sell (E+)" Rating from Weiss RatingsMarketBeatWeiss Ratings reaffirmed a "sell (e+)" rating on shares of Cerus in a research report on Friday.NASDAQ:CERSRead Cerus (NASDAQ:CERS) Earns "Sell (E+)" Rating from Weiss Ratings2 hours agoWeiss Ratings Reaffirms Sell (D) Rating for Certara (NASDAQ:CERT)MarketBeatWeiss Ratings reaffirmed a "sell (d)" rating on shares of Certara in a research report on Friday.NASDAQ:CERTRead Weiss Ratings Reaffirms Sell (D) Rating for Certara (NASDAQ:CERT)2 hours agoCeriBell (NASDAQ:CBLL) Receives Sell (E+) Rating from Weiss RatingsMarketBeatWeiss Ratings reaffirmed a "sell (e+)" rating on shares of CeriBell in a research note on Friday.NASDAQ:CBLLRead CeriBell (NASDAQ:CBLL) Receives Sell (E+) Rating from Weiss Ratings2 hours agoCeragon Networks (NASDAQ:CRNT) Given "Sell (D)" Rating at Weiss RatingsMarketBeatWeiss Ratings reiterated a "sell (d)" rating on shares of Ceragon Networks in a research note on Friday.NASDAQ:CRNTRead Ceragon Networks (NASDAQ:CRNT) Given "Sell (D)" Rating at Weiss Ratings2 hours agoWeiss Ratings Reaffirms "Sell (E+)" Rating for Century Therapeutics (NASDAQ:IPSC)MarketBeatWeiss Ratings reaffirmed a "sell (e+)" rating on shares of Century Therapeutics in a research note on Friday.NASDAQ:IPSCRead Weiss Ratings Reaffirms "Sell (E+)" Rating for Century Therapeutics (NASDAQ:IPSC)2 hours agoCentury Communities (NYSE:CCS) Receives Hold (C) Rating from Weiss RatingsMarketBeatWeiss Ratings restated a "hold (c)" rating on shares of Century Communities in a research report on Friday.NYSE:CCSRead Century Communities (NYSE:CCS) Receives Hold (C) Rating from Weiss Ratings Trending News1D-Wave Quantum (NYSE:QBTS) Stock Price Down 6.2% - Here's Why2Oracle (NYSE:ORCL) EVP Sells $1,403,100.00 in Stock3Nebius Group (NBIS) to Release Earnings on Wednesday4Plug Power (NASDAQ:PLUG) Shares Down 8.2% - Here's Why5Rolls-Royce Holdings plc (LON:RR) Shares Down 2.8% - Here's What Happened6Verizon Communications (NYSE:VZ) Stock Price Down 1.1% Following Analyst Downgrade7HCM II Acquisition (NASDAQ:HOND) Stock Price Down 10.9% - Here's What Happened8Krispy Kreme (NASDAQ:DNUT) Shares Up 15.5% - Here's Why All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoCentury Aluminum's (CENX) "Hold (C)" Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:CENXRead Century Aluminum's (CENX) "Hold (C)" Rating Reaffirmed at Weiss Ratings2 hours agoWeiss Ratings Reiterates Sell (D+) Rating for Central Puerto (NYSE:CEPU)MarketBeatNYSE:CEPURead Weiss Ratings Reiterates Sell (D+) Rating for Central Puerto (NYSE:CEPU)2 hours agoCentral Plains Bancshares' (CPBI) Hold (C-) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:CPBIRead Central Plains Bancshares' (CPBI) Hold (C-) Rating Reaffirmed at Weiss Ratings2 hours agoCPB (NYSE:CPF) Given Buy (B-) Rating at Weiss RatingsMarketBeatNYSE:CPFRead CPB (NYSE:CPF) Given Buy (B-) Rating at Weiss Ratings2 hours agoCentral Garden & Pet (NASDAQ:CENT) Receives "Hold (C-)" Rating from Weiss RatingsMarketBeatNASDAQ:CENTRead Central Garden & Pet (NASDAQ:CENT) Receives "Hold (C-)" Rating from Weiss Ratings2 hours agoWeiss Ratings Reiterates "Hold (C)" Rating for Centrais El�tricas Brasileiras (NYSE:EBR)MarketBeatNYSE:EBRRead Weiss Ratings Reiterates "Hold (C)" Rating for Centrais El�tricas Brasileiras (NYSE:EBR)2 hours agoWeiss Ratings Reaffirms "Sell (D-)" Rating for Centessa Pharmaceuticals (NASDAQ:CNTA)MarketBeatNASDAQ:CNTARead Weiss Ratings Reaffirms "Sell (D-)" Rating for Centessa Pharmaceuticals (NASDAQ:CNTA)2 hours agoCenterspace's (CSR) "Sell (D+)" Rating Reaffirmed at Weiss RatingsMarketBeatNYSE:CSRRead Centerspace's (CSR) "Sell (D+)" Rating Reaffirmed at Weiss Ratings2 hours agoCenterra Gold (NYSE:CGAU) Receives Hold (C) Rating from Weiss RatingsMarketBeatNYSE:CGAURead Centerra Gold (NYSE:CGAU) Receives Hold (C) Rating from Weiss Ratings2 hours agoCenterPoint Energy (NYSE:CNP) Earns "Buy (B-)" Rating from Weiss RatingsMarketBeatNYSE:CNPRead CenterPoint Energy (NYSE:CNP) Earns "Buy (B-)" Rating from Weiss Ratings2 hours agoWeiss Ratings Reiterates "Sell (D)" Rating for Centene (NYSE:CNC)MarketBeatNYSE:CNCRead Weiss Ratings Reiterates "Sell (D)" Rating for Centene (NYSE:CNC)2 hours agoHammond Power Solutions (TSE:HPS.A) Trading 27.5% Higher - What's Next?MarketBeatTSE:HPS.ARead Hammond Power Solutions (TSE:HPS.A) Trading 27.5% Higher - What's Next?2 hours agoEKF Diagnostics (LON:EKF) Trading Down 7% - Should You Sell?MarketBeatLON:EKFRead EKF Diagnostics (LON:EKF) Trading Down 7% - Should You Sell?2 hours agoImmuPharma (LON:IMM) Shares Down 6.3% - Should You Sell?MarketBeatLON:IMMRead ImmuPharma (LON:IMM) Shares Down 6.3% - Should You Sell?2 hours agoCemex (NYSE:CX) Given "Hold (C)" Rating at Weiss RatingsMarketBeatNYSE:CXRead Cemex (NYSE:CX) Given "Hold (C)" Rating at Weiss Ratings2 hours agoCementos Pacasmayo S.A.A.'s (CPAC) Hold (C) Rating Reiterated at Weiss RatingsMarketBeatNYSE:CPACRead Cementos Pacasmayo S.A.A.'s (CPAC) Hold (C) Rating Reiterated at Weiss Ratings2 hours agoCelularity (NASDAQ:CELU) Earns "Sell (D-)" Rating from Weiss RatingsMarketBeatNASDAQ:CELURead Celularity (NASDAQ:CELU) Earns "Sell (D-)" Rating from Weiss Ratings2 hours agoCellectis (NASDAQ:CLLS) Given "Sell (D-)" Rating at Weiss RatingsMarketBeatNASDAQ:CLLSRead Cellectis (NASDAQ:CLLS) Given "Sell (D-)" Rating at Weiss Ratings2 hours agoCellebrite DI's (CLBT) "Sell (D+)" Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:CLBTRead Cellebrite DI's (CLBT) "Sell (D+)" Rating Reaffirmed at Weiss Ratings2 hours agoWeiss Ratings Reaffirms Sell (D-) Rating for Celldex Therapeutics (NASDAQ:CLDX)MarketBeatNASDAQ:CLDXRead Weiss Ratings Reaffirms Sell (D-) Rating for Celldex Therapeutics (NASDAQ:CLDX)2 hours agoWeiss Ratings Reaffirms Sell (D-) Rating for Celcuity (NASDAQ:CELC)MarketBeatNASDAQ:CELCRead Weiss Ratings Reaffirms Sell (D-) Rating for Celcuity (NASDAQ:CELC)2 hours agoCelanese (NYSE:CE) Given Sell (D) Rating at Weiss RatingsMarketBeatNYSE:CERead Celanese (NYSE:CE) Given Sell (D) Rating at Weiss Ratings2 hours agoCECO Environmental (NASDAQ:CECO) Earns Buy (B-) Rating from Weiss RatingsMarketBeatNASDAQ:CECORead CECO Environmental (NASDAQ:CECO) Earns Buy (B-) Rating from Weiss Ratings2 hours agoCCC Intelligent Solutions (NASDAQ:CCCS) Given Sell (D) Rating at Weiss RatingsMarketBeatNASDAQ:CCCSRead CCC Intelligent Solutions (NASDAQ:CCCS) Given Sell (D) Rating at Weiss Ratings Featured Articles and OffersJPMorgan Crushes Q3; But Is the Steady Eddy Stock Hitting A Wall?By Leo Miller | October 19, 2025If You Keep Cash In A U.S. Bank Account… Read This NOWFrom Banyan Hill Publishing (Ad)Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done YetBy Dan Schmidt | October 20, 2025Archer’s Recent String of Victories Signals a New Phase of GrowthBy Jeffrey Neal Johnson | October 22, 2025The Best AI for Picking Stocks, Ranked by PerformanceBy Thomas Hughes | October 23, 2025The Republican party is falling apartFrom Porter & Company (Ad)2 Ways to Trade Qualcomm Ahead of November’s EarningsBy Sam Quirke | October 21, 2025Warner Bros. Bidding War Potential: How High Could WBD Shares Go?By Leo Miller | October 23, 2025 Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
